Dose‐Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs
Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1695
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2020
Authors
Publisher
Wiley